Heron Therapeutics Inc.
08/02/2021 | Press release | Distributed by Public on 08/02/2021 15:01
Letter from OUM, dated August 2, 2021 (Form 8-K)
August 2, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-7561
Ladies and Gentlemen:
We have read Heron Therapeutics, Inc.'s statements included under Item 4.01 of its Form 8‑K dated August 2, 2021, and are in agreement with the statements contained therein concerning our firm in response to Item 304(a) of Regulation S-K.
Very truly yours,
/s/ OUM & Co. LLP